Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS

Authors

  • E.V. Ryabokon Zaporizhzhya State Medical University, Ukraine,
  • T.E. Onishenko Zaporizhzhya State Medical University, Ukraine,
  • E.L. Koltunik Zaporizhzhya State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1237.2013.2.17810

Keywords:

HIV-infection, highly active antiretroviral therapy, kidney affection

Abstract

As a result of the analysis of 330 archival patient’s cards of patients with HIV/AIDS who received highly active antiretroviral therapy with the inclusion of tenofovir in the treatment scheme, kidney affection has been fixed in 1,5 % of cases only in patients with the acquired immunodeficiency syndrome, accompanying chemotherapy concerning tuberculosis and/or pneumocystosis, existence of other background somatic pathology.

References

Global report: UNAIDS report on the global AIDSepidemic 1010 [електронний ресурс] / UNAIDS // WHO Library. – 2010. – 364 p. – Режим доступу: http://www.unaids.org/globalreport/

A shift of the endothelial dysfunction markers in patients with HIV-infection.AIDS under HAART / V.D. Moskaliuk, V.D. Sorokhan, S.R. Melenko et al. // Інфекційні хвороби. – 2013. – №2 (72). – С. 26–28.

Андросова О.С. Морфофункціональні зміни стану печінки при синдромі набутого імунодефіциту людини: автореф. дис. ... к. мед. н. / Андросова О.С. – К., 2013. – 21 с.

Патоморфологія печінки у ВІЛ-інфікованих пацієнтів / Н.В. Матієвська, В.М. Циркунов, Н.І. Прокопчик [та ін.] // Інфекційні хвороби. – 2012. – №3 (69). – С. 15–23.

Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression / K.C. Abbott, S.J. Swanson, L.Y. Agodoa [et al.] // J. Am. S. Nephrol. – 2004. – Vol. 15. – P. 1633–1639.

Rho M. Nephrotoxicity associated with antiretroviral therapy in HIV infected patients / M. Rho, M.A. Perazella // Curr. Drug. Saf. – 2007. – Vol. 2. – P. 147–154.

Wyatt C.M. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality / C.M. Wyatt // AIDS. – 2006. – Vol. 20 (4). – P. 561–565.

Бартлетт Д. Клинические аспекты ВИЧ-инфекции / Д. Бартлетт, Д. Галлант, П. Фам. – М.: Р.Валент, 2012. – 528 с.

Юрин О.Г. Первый опыт применения тенофовира при лечении больных ВИЧ-инфекцией в России / О.Г. Юрин, М.Д. Голиусова, М.О. Деулина [и соавт.] // Эпидемиология и инфекционные болезни. – 2013. – №1. – С. 62–69.

Fanconi syndrome and renal failure induced by tenofovir: a first case report / D. Verhelst, M. Monge, J.L. Meynard [et al.] // Am. J. Kidney Dis. – 2002. – Vol. 40 (6). – P. 1331–1333.

Horberg M. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients / M. Horberg, B. Tang, W. Towner [et al.] // J. Acquir. Immune. Defic. Syndr. – 2010. – Vol. 53. – P. 62–69.

Jones R. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study / R. Jones // J. Acquir. Immune. Defic. Syndr. – 2004. – Vol. 37. – P. 1489–1495.

Нефротоксические эффекты высокоактивной антиретровирусной терапии / Н.Д. Ющук, Г.В. Волгина, Н.А. Томилина [и соавт.] // Нефрология и диализ. – 2010. – №3. – С. 154–163.

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions / A.E. Zimmermann, T. Pizzoferrato, J.Bedford [et al.] // Clin. Infect. Dis. – 2006. – Vol. 42 (2). – P. 283–290.

Downloads

How to Cite

1.
Ryabokon E, Onishenko T, Koltunik E. Features of kidney affection in the conditions of highly active antiretroviral therapy in patients with HIV/AIDS. Pathologia [Internet]. 2013Sep.30 [cited 2024Nov.23];(2). Available from: http://pat.zsmu.edu.ua/article/view/17810

Issue

No. 2 (2013)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).